Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Trends and regional differences in antidiabetic medication use: a nationwide retrospective observational study

Fig. 2

Change in regional antidiabetic drug group utilization between 2015 and 2021. Red square and lines: county average ± 95% CI; Yellow circle: county utilization data. A10: Antidiabetics total, A10A: Insulins, A10BA+: Biguanides and combinations, A10BB: Sulfonylureas, A10BD: Combinations of antidiabetics, A10BF: Alpha glucosidase inhibitors, A10BG+: Thiazolidindiones and combinations, A10BH+: dipeptidyl peptidase 4 inhibitors and combinations, A10BJ+: glucagon-like peptide-1 analogues and combinations, A10BK+: sodium-glucose co-transporter 2 inhibitors and combinations, A10BX: Glinides

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us